"HIV Integrase Inhibitors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Inhibitors of HIV INTEGRASE, an enzyme required for integration of viral DNA into cellular DNA.
| Descriptor ID |
D019428
|
| MeSH Number(s) |
D27.505.519.389.375.400 D27.505.954.122.388.077.088.314
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "HIV Integrase Inhibitors".
Below are MeSH descriptors whose meaning is more specific than "HIV Integrase Inhibitors".
This graph shows the total number of publications written about "HIV Integrase Inhibitors" by people in this website by year, and whether "HIV Integrase Inhibitors" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2007 | 1 | 0 | 1 |
| 2009 | 3 | 0 | 3 |
| 2010 | 1 | 0 | 1 |
| 2012 | 2 | 0 | 2 |
| 2013 | 1 | 0 | 1 |
| 2016 | 1 | 0 | 1 |
| 2020 | 1 | 0 | 1 |
| 2022 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "HIV Integrase Inhibitors" by people in Profiles.
-
Impact of Integrase Strand Transfer Inhibitor Use During Pregnancy on Viral Suppression at Delivery and Infant Outcomes: A Statewide Retrospective Cohort Study. J Acquir Immune Defic Syndr. 2022 04 01; 89(4):448-453.
-
Weight gain and integrase inhibitors. Curr Opin Infect Dis. 2020 02; 33(1):10-19.
-
Integrase inhibitors in late pregnancy and rapid HIV viral load reduction. Am J Obstet Gynecol. 2016 Mar; 214(3):385.e1-7.
-
Once-daily dolutegravir versus twice-daily raltegravir in antiretroviral-naive adults with HIV-1 infection (SPRING-2 study): 96 week results from a randomised, double-blind, non-inferiority trial. Lancet Infect Dis. 2013 Nov; 13(11):927-35.
-
Update on raltegravir and the development of new integrase strand transfer inhibitors. South Med J. 2012 Jul; 105(7):370-8.
-
Role of raltegravir in HIV-1 management. Ann Pharmacother. 2012 Apr; 46(4):578-89.
-
Raltegravir--beauty and the beast. Both the advantages and the limitations of this integrase inhibitor were evident this year. J Watch AIDS Clin Care. 2010 Jan; 22(1):4.
-
Report from the 16th Conference on Retroviruses and Opportunistic Infections. SWITCHMRK: an avoidable raltegravir disaster. J Watch AIDS Clin Care. 2009 Apr; 21(4):30-1.
-
1,3,4-Oxadiazole substituted naphthyridines as HIV-1 integrase inhibitors. Part 2: SAR of the C5 position. Bioorg Med Chem Lett. 2009 Mar 15; 19(6):1807-10.
-
The use of oxadiazole and triazole substituted naphthyridines as HIV-1 integrase inhibitors. Part 1: Establishing the pharmacophore. Bioorg Med Chem Lett. 2009 Mar 15; 19(6):1802-6.